Following claims that the U.S. Supreme Court’s decision to overturn the Chevron precedent could cancel marijuana rescheduling, a leading expert has provided a rebuttal.
Matt Zorn, an attorney and partner at the lawfirm Yetter Coleman LLP, detailed his perspective in an article on his Substack On Drugs. Zorn says that “overturning Chevron was a good thing for rescheduling.”
He further explained to Green Market Report that the ruling “changes nothing” about the ongoing process to reclassify cannabis from Schedule I to Schedule III.
Continue reading